Status:
RECRUITING
Association of Sarcopenia With Rocuronium Use in Liver Transplant Recipients
Lead Sponsor:
Inonu University
Conditions:
Sarcopenia
Sarcopenia in Liver Cirrhosis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Patients will be informed by obtaining consent when they meet the inclusion criteria. Written consent will be obtained when the patient arrives in the operating room. The patient's characteristics (...
Detailed Description
This prospective observational study will investigate the effect of sarcopenia on rocuronium use in patients scheduled for liver transplantation. The study population will consist of ASA II-III patien...
Eligibility Criteria
Inclusion
- Patients with American Society of Anesthesiologists (ASA) 2-3,
- Patients over the age of 18,
- Liver transplant recipient candidates who have agreed to receive an organ transplant
Exclusion
- Patients who are unconscious enough to not be included in the study (patients for whom consent cannot be obtained and the study cannot be explained)
- Patients under the age of 18
- Patients aged 65 and over
- Patients with advanced renal failure
- Patients with massive ascites in the abdomen
- Patients with advanced heart failure or high pulmonary artery pressure for whom routine anesthesia induction protocols must be excluded
- Patients with psychosis or substance abuse Patients with a known adverse reaction to rocuronium
Key Trial Info
Start Date :
April 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT06909942
Start Date
April 1 2025
End Date
February 1 2026
Last Update
December 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Turgut Ozal Medicine Center Liver Transplantation Institute
Malatya, Battalgazi, Turkey (Türkiye), 44040